ClinicalTrials.Veeva

Menu

Community Co-produced Action for Improved Access to Cervical Cancer Screening in Cameroon (Act4CC)

P

Prof. Patrick Petignat

Status

Enrolling

Conditions

Cervical Cancer Screening

Treatments

Other: Community co-produced action
Other: Standard screening strategy

Study type

Interventional

Funder types

Other

Identifiers

NCT06640075
1020/31/01/2024/CE/CRERSH-OU/V
AO_2023-00019 (Other Identifier)

Details and patient eligibility

About

Background - The burden of cervical cancer is unequally distributed globally, with over 90% of deaths occurring in low- and middle-income countries (LMICs), mainly due to insufficient uptake of preventive measures such as screening. In 2020, the World Health Organization launched a global initiative for the worldwide elimination of cervical cancer as a public health issue, setting a target of 70% of women screened with a high-performance test. In Cameroon, this target is far from being reached, and rural communities are disproportionately affected by low uptake of screening services. Recently, a new cervical cancer screening program has launched in the Bafoussam Regional Hospital, in the capital of the Mifi Health District, as part of a larger research project. To develop a context-specific strategy improving access to screening for women living in rural areas of the district, the active participation of community members for the co-development and implementation of local strategies for cervical cancer screening may be key to improving population screening coverage.

Objective - The aim of this study is to evaluate the use of community co-produced action (CCA) for the development and implementation of HPV-based cervical cancer screening strategies compared to a traditional hospital-based approach in rural areas of the Mifi Health District in Cameroon.

Methods - Using a cluster-randomized study design, participatory workshops with community members will be led in 7 rural health areas assigned to the intervention arm, with the aim of codeveloping local strategies for HPV-based cervical cancer screening adapted to the setting. The co-produced strategies may include raising awareness among eligible women (aged 30-49 years, or 25-49 years if HIV-positive), as well as facilitating access to screening tests, results and follow-up. Women living in one of the 7 health areas assigned to the control arm will be invited by community health workers to undergo screening at the Bafoussam Regional Hospital. In both study arms, screened women will be included in the GENOVA study, a cervical cancer screening trial offering free-of- charge HPV testing followed by triage by visual inspection or genotyping for HPV-positive women, and free treatment according to triage results. CCA will be evaluated by assessing its effectiveness for screening uptake. Screening coverage among eligible women will be estimated during one year after implementation of screening strategies in both study arms, based on population statistics provided by the Mifi health district for each health area.

Expected results - Developing context-sensitive solutions to cervical cancer screening through a community-based participatory approach in rural areas of the Mifi health district is expected to improve screening participation rate.

Enrollment

800 estimated patients

Sex

Female

Ages

25 to 49 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Women aged 30-49 years old (25-49 years old if HIV-positive)
  • Residency in one of the 14 rural health areas of Mifi health district
  • Ability to give signed informed consent

Exclusion criteria

  • known cervical cancer
  • symptoms compatible with cervical cancer
  • previous hysterectomy
  • terminal disease other than cervical cancer
  • cervical cancer screening test in the last 5 years (3 years if HIV-positive)
  • pregnancy at the time of screening
  • lack of discernment capacity

Trial design

Primary purpose

Screening

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

800 participants in 2 patient groups

Community co-produced action
Experimental group
Description:
Participatory workshops will be conducted with community members by a multidisciplinary team with the aim to co-develop a strategy for cervical cancer screening adapted to the local setting (including primary HPV screening, triage of HPV-positive patients and treatment of patients triaged positive).
Treatment:
Other: Community co-produced action
Standard screening strategy
Active Comparator group
Description:
Recruitment of study participants will be coordinated centrally at district level (from the Bafoussam Regional Hospital) following procedures previously established in a cervical cancer screening program in the health district of Dschang.
Treatment:
Other: Standard screening strategy

Trial contacts and locations

1

Loading...

Central trial contact

Ania M Wisniak, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems